Potential Cardiovascular Benefits in the General Population of Men with ED, in Diabetics, in Men with Other Risk Factors: Are PDE-5 Inhibitors Cardioprotective? | VuMedi

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

10 seconds

Playback speed

"Princeton 4: PDE5 Inhibitors and Cardiac Health Symposium.” Huntington Medical Research Institutes, Pasadena, CA. Friday, March 10th, 2023.

Potential Cardiovascular Benefits in the General Population of Men with ED, in Diabetics, in Men with Other Risk Factors: Are PDE-5 Inhibitors Cardioprotective?

By "Princeton 4: PDE5 Inhibitors and Cardiac Health Symposium.” Huntington Medical Research Institutes, Pasadena, CA. Friday, March 10th, 2023. FEATURING Robert Kloner

By "Princeton 4: PDE5 Inhibitors and Cardiac Health Symposium.” Huntington Medical Research Institutes, Pasadena, CA. Friday, March 10th, 2023. FEATURING Robert Kloner

421 views

July 11, 2023

Speaker Name and Title: Robert A. Kloner MD, PhD, CSO
The Princeton 4 meeting was ...
read more ↘

Comments 0

Login to view comments. Click here to Login